nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—brain cancer	0.702	1	CbGaD
Bosentan—CYP3A4—Temozolomide—brain cancer	0.0463	0.486	CbGbCtD
Bosentan—CYP3A4—Lomustine—brain cancer	0.0394	0.414	CbGbCtD
Bosentan—CYP3A4—Etoposide—brain cancer	0.00951	0.0999	CbGbCtD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00743	0.153	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00532	0.109	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00515	0.106	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00369	0.0757	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00178	0.0366	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—TRPC6—brain cancer	0.00131	0.027	CbGpPWpGaD
Bosentan—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—brain cancer	0.00114	0.0235	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—TRPC6—brain cancer	0.00094	0.0193	CbGpPWpGaD
Bosentan—ABCB11—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000852	0.0175	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—SMO—brain cancer	0.000689	0.0141	CbGpPWpGaD
Bosentan—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000599	0.0123	CbGpPWpGaD
Bosentan—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000577	0.0118	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—PTCH2—brain cancer	0.000559	0.0115	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—TRPC6—brain cancer	0.00055	0.0113	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000492	0.0101	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—OR4C12—brain cancer	0.00049	0.0101	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—OR14C36—brain cancer	0.00049	0.0101	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—OR4C12—brain cancer	0.000445	0.00914	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—OR14C36—brain cancer	0.000445	0.00914	CbGpPWpGaD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000412	0.00845	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—PTCH2—brain cancer	0.0004	0.00821	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—TRPC6—brain cancer	0.000394	0.00809	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000392	0.00805	CbGpPWpGaD
Bosentan—Pneumonia—Carmustine—brain cancer	0.00039	0.00253	CcSEcCtD
Bosentan—Shock—Procarbazine—brain cancer	0.000389	0.00253	CcSEcCtD
Bosentan—Pollakiuria—Temozolomide—brain cancer	0.000389	0.00252	CcSEcCtD
Bosentan—Thrombocytopenia—Procarbazine—brain cancer	0.000387	0.00251	CcSEcCtD
Bosentan—Chills—Hydroxyurea—brain cancer	0.000387	0.00251	CcSEcCtD
Bosentan—Tachycardia—Procarbazine—brain cancer	0.000386	0.00251	CcSEcCtD
Bosentan—Weight increased—Temozolomide—brain cancer	0.000383	0.00248	CcSEcCtD
Bosentan—Hyperhidrosis—Procarbazine—brain cancer	0.000382	0.00248	CcSEcCtD
Bosentan—Renal failure—Carmustine—brain cancer	0.000381	0.00248	CcSEcCtD
Bosentan—Weight decreased—Temozolomide—brain cancer	0.000381	0.00247	CcSEcCtD
Bosentan—Hyperglycaemia—Temozolomide—brain cancer	0.000379	0.00246	CcSEcCtD
Bosentan—Stomatitis—Carmustine—brain cancer	0.000378	0.00245	CcSEcCtD
Bosentan—Urinary tract infection—Carmustine—brain cancer	0.000377	0.00245	CcSEcCtD
Bosentan—Pneumonia—Temozolomide—brain cancer	0.000377	0.00245	CcSEcCtD
Bosentan—Anorexia—Procarbazine—brain cancer	0.000377	0.00245	CcSEcCtD
Bosentan—Erythema—Hydroxyurea—brain cancer	0.000375	0.00243	CcSEcCtD
Bosentan—Infestation—Temozolomide—brain cancer	0.000375	0.00243	CcSEcCtD
Bosentan—Infestation NOS—Temozolomide—brain cancer	0.000375	0.00243	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000372	0.00241	CcSEcCtD
Bosentan—Cardiac arrest—Etoposide—brain cancer	0.00037	0.0024	CcSEcCtD
Bosentan—Nausea—Lomustine—brain cancer	0.00037	0.0024	CcSEcCtD
Bosentan—Hypotension—Procarbazine—brain cancer	0.00037	0.0024	CcSEcCtD
Bosentan—Stomatitis—Temozolomide—brain cancer	0.000366	0.00237	CcSEcCtD
Bosentan—Urinary tract infection—Temozolomide—brain cancer	0.000365	0.00237	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00036	0.00234	CcSEcCtD
Bosentan—Insomnia—Procarbazine—brain cancer	0.000358	0.00232	CcSEcCtD
Bosentan—Paraesthesia—Procarbazine—brain cancer	0.000355	0.00231	CcSEcCtD
Bosentan—Hepatobiliary disease—Temozolomide—brain cancer	0.000355	0.0023	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000352	0.00723	CbGpPWpGaD
Bosentan—Sinusitis—Temozolomide—brain cancer	0.000352	0.00228	CcSEcCtD
Bosentan—Somnolence—Procarbazine—brain cancer	0.000352	0.00228	CcSEcCtD
Bosentan—Cramp muscle—Etoposide—brain cancer	0.000351	0.00228	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—OR4C12—brain cancer	0.000351	0.0072	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—OR14C36—brain cancer	0.000351	0.0072	CbGpPWpGaD
Bosentan—Haemoglobin—Carmustine—brain cancer	0.00035	0.00227	CcSEcCtD
Bosentan—Haemorrhage—Carmustine—brain cancer	0.000348	0.00226	CcSEcCtD
Bosentan—Anaemia—Hydroxyurea—brain cancer	0.000347	0.00225	CcSEcCtD
Bosentan—Hypoaesthesia—Carmustine—brain cancer	0.000347	0.00225	CcSEcCtD
Bosentan—Decreased appetite—Procarbazine—brain cancer	0.000344	0.00223	CcSEcCtD
Bosentan—Oedema peripheral—Carmustine—brain cancer	0.000343	0.00223	CcSEcCtD
Bosentan—Fatigue—Procarbazine—brain cancer	0.000341	0.00221	CcSEcCtD
Bosentan—Haemoglobin—Temozolomide—brain cancer	0.000338	0.0022	CcSEcCtD
Bosentan—Constipation—Procarbazine—brain cancer	0.000338	0.0022	CcSEcCtD
Bosentan—Pain—Procarbazine—brain cancer	0.000338	0.0022	CcSEcCtD
Bosentan—Haemorrhage—Temozolomide—brain cancer	0.000337	0.00218	CcSEcCtD
Bosentan—Hepatitis—Temozolomide—brain cancer	0.000337	0.00218	CcSEcCtD
Bosentan—Leukopenia—Hydroxyurea—brain cancer	0.000336	0.00218	CcSEcCtD
Bosentan—Hypoaesthesia—Temozolomide—brain cancer	0.000335	0.00217	CcSEcCtD
Bosentan—Urinary tract disorder—Temozolomide—brain cancer	0.000332	0.00216	CcSEcCtD
Bosentan—Oedema peripheral—Temozolomide—brain cancer	0.000332	0.00215	CcSEcCtD
Bosentan—Bronchospasm—Etoposide—brain cancer	0.000331	0.00215	CcSEcCtD
Bosentan—Urethral disorder—Temozolomide—brain cancer	0.00033	0.00214	CcSEcCtD
Bosentan—Sweating increased—Etoposide—brain cancer	0.000328	0.00213	CcSEcCtD
Bosentan—Eye disorder—Carmustine—brain cancer	0.000326	0.00211	CcSEcCtD
Bosentan—Gastrointestinal pain—Procarbazine—brain cancer	0.000323	0.0021	CcSEcCtD
Bosentan—Flushing—Carmustine—brain cancer	0.000323	0.0021	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—OR4C12—brain cancer	0.000318	0.00654	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—OR14C36—brain cancer	0.000318	0.00654	CbGpPWpGaD
Bosentan—Erythema multiforme—Temozolomide—brain cancer	0.000318	0.00207	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000317	0.00206	CcSEcCtD
Bosentan—Discomfort—Hydroxyurea—brain cancer	0.000316	0.00205	CcSEcCtD
Bosentan—Neutropenia—Etoposide—brain cancer	0.000315	0.00204	CcSEcCtD
Bosentan—Eye disorder—Temozolomide—brain cancer	0.000315	0.00204	CcSEcCtD
Bosentan—Urticaria—Procarbazine—brain cancer	0.000314	0.00204	CcSEcCtD
Bosentan—Tinnitus—Temozolomide—brain cancer	0.000314	0.00204	CcSEcCtD
Bosentan—Abdominal pain—Procarbazine—brain cancer	0.000313	0.00203	CcSEcCtD
Bosentan—Body temperature increased—Procarbazine—brain cancer	0.000313	0.00203	CcSEcCtD
Bosentan—Flushing—Temozolomide—brain cancer	0.000312	0.00203	CcSEcCtD
Bosentan—Cardiac disorder—Temozolomide—brain cancer	0.000312	0.00203	CcSEcCtD
Bosentan—Oedema—Hydroxyurea—brain cancer	0.000306	0.00199	CcSEcCtD
Bosentan—Angiopathy—Temozolomide—brain cancer	0.000305	0.00198	CcSEcCtD
Bosentan—Mental disorder—Carmustine—brain cancer	0.000305	0.00198	CcSEcCtD
Bosentan—Infection—Hydroxyurea—brain cancer	0.000304	0.00197	CcSEcCtD
Bosentan—Immune system disorder—Temozolomide—brain cancer	0.000304	0.00197	CcSEcCtD
Bosentan—Mediastinal disorder—Temozolomide—brain cancer	0.000303	0.00197	CcSEcCtD
Bosentan—Erythema—Carmustine—brain cancer	0.000303	0.00197	CcSEcCtD
Bosentan—Malnutrition—Carmustine—brain cancer	0.000303	0.00197	CcSEcCtD
Bosentan—Chills—Temozolomide—brain cancer	0.000302	0.00196	CcSEcCtD
Bosentan—Pneumonia—Etoposide—brain cancer	0.000302	0.00196	CcSEcCtD
Bosentan—Nervous system disorder—Hydroxyurea—brain cancer	0.0003	0.00195	CcSEcCtD
Bosentan—Infestation NOS—Etoposide—brain cancer	0.0003	0.00195	CcSEcCtD
Bosentan—Infestation—Etoposide—brain cancer	0.0003	0.00195	CcSEcCtD
Bosentan—Thrombocytopenia—Hydroxyurea—brain cancer	0.0003	0.00195	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000298	0.00193	CcSEcCtD
Bosentan—Skin disorder—Hydroxyurea—brain cancer	0.000297	0.00193	CcSEcCtD
Bosentan—Acute coronary syndrome—Etoposide—brain cancer	0.000296	0.00192	CcSEcCtD
Bosentan—Renal failure—Etoposide—brain cancer	0.000295	0.00191	CcSEcCtD
Bosentan—Mental disorder—Temozolomide—brain cancer	0.000295	0.00191	CcSEcCtD
Bosentan—Myocardial infarction—Etoposide—brain cancer	0.000294	0.00191	CcSEcCtD
Bosentan—Back pain—Carmustine—brain cancer	0.000293	0.0019	CcSEcCtD
Bosentan—Erythema—Temozolomide—brain cancer	0.000293	0.0019	CcSEcCtD
Bosentan—Malnutrition—Temozolomide—brain cancer	0.000293	0.0019	CcSEcCtD
Bosentan—Stomatitis—Etoposide—brain cancer	0.000293	0.0019	CcSEcCtD
Bosentan—Jaundice—Etoposide—brain cancer	0.000293	0.0019	CcSEcCtD
Bosentan—Anorexia—Hydroxyurea—brain cancer	0.000292	0.00189	CcSEcCtD
Bosentan—Hypersensitivity—Procarbazine—brain cancer	0.000291	0.00189	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—SHH—brain cancer	0.000288	0.00591	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PTCH2—brain cancer	0.000287	0.00589	CbGpPWpGaD
Bosentan—Vision blurred—Carmustine—brain cancer	0.000286	0.00185	CcSEcCtD
Bosentan—Tremor—Carmustine—brain cancer	0.000284	0.00184	CcSEcCtD
Bosentan—Asthenia—Procarbazine—brain cancer	0.000284	0.00184	CcSEcCtD
Bosentan—Hepatobiliary disease—Etoposide—brain cancer	0.000284	0.00184	CcSEcCtD
Bosentan—Back pain—Temozolomide—brain cancer	0.000283	0.00184	CcSEcCtD
Bosentan—Anaemia—Carmustine—brain cancer	0.00028	0.00182	CcSEcCtD
Bosentan—Pruritus—Procarbazine—brain cancer	0.00028	0.00182	CcSEcCtD
Bosentan—Vision blurred—Temozolomide—brain cancer	0.000276	0.00179	CcSEcCtD
Bosentan—Tremor—Temozolomide—brain cancer	0.000275	0.00178	CcSEcCtD
Bosentan—Dyspnoea—Hydroxyurea—brain cancer	0.000273	0.00177	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—PTCH1—brain cancer	0.000273	0.0056	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—SMO—brain cancer	0.000273	0.0056	CbGpPWpGaD
Bosentan—Somnolence—Hydroxyurea—brain cancer	0.000272	0.00177	CcSEcCtD
Bosentan—Leukopenia—Carmustine—brain cancer	0.000271	0.00176	CcSEcCtD
Bosentan—Anaemia—Temozolomide—brain cancer	0.000271	0.00176	CcSEcCtD
Bosentan—Diarrhoea—Procarbazine—brain cancer	0.000271	0.00176	CcSEcCtD
Bosentan—Dyspepsia—Hydroxyurea—brain cancer	0.00027	0.00175	CcSEcCtD
Bosentan—Hypoaesthesia—Etoposide—brain cancer	0.000268	0.00174	CcSEcCtD
Bosentan—Angioedema—Temozolomide—brain cancer	0.000268	0.00174	CcSEcCtD
Bosentan—Decreased appetite—Hydroxyurea—brain cancer	0.000266	0.00173	CcSEcCtD
Bosentan—Urinary tract disorder—Etoposide—brain cancer	0.000266	0.00173	CcSEcCtD
Bosentan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000264	0.00172	CcSEcCtD
Bosentan—Urethral disorder—Etoposide—brain cancer	0.000264	0.00171	CcSEcCtD
Bosentan—Fatigue—Hydroxyurea—brain cancer	0.000264	0.00171	CcSEcCtD
Bosentan—Vertigo—Temozolomide—brain cancer	0.000263	0.00171	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—OR4C12—brain cancer	0.000263	0.0054	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—OR14C36—brain cancer	0.000263	0.0054	CbGpPWpGaD
Bosentan—Leukopenia—Temozolomide—brain cancer	0.000262	0.0017	CcSEcCtD
Bosentan—Constipation—Hydroxyurea—brain cancer	0.000262	0.0017	CcSEcCtD
Bosentan—Pain—Hydroxyurea—brain cancer	0.000262	0.0017	CcSEcCtD
Bosentan—Dizziness—Procarbazine—brain cancer	0.000262	0.0017	CcSEcCtD
Bosentan—Palpitations—Temozolomide—brain cancer	0.000259	0.00168	CcSEcCtD
Bosentan—Chest pain—Carmustine—brain cancer	0.000258	0.00168	CcSEcCtD
Bosentan—Anxiety—Carmustine—brain cancer	0.000257	0.00167	CcSEcCtD
Bosentan—Cough—Temozolomide—brain cancer	0.000256	0.00166	CcSEcCtD
Bosentan—Erythema multiforme—Etoposide—brain cancer	0.000255	0.00165	CcSEcCtD
Bosentan—Eye disorder—Etoposide—brain cancer	0.000252	0.00163	CcSEcCtD
Bosentan—Vomiting—Procarbazine—brain cancer	0.000252	0.00163	CcSEcCtD
Bosentan—Flushing—Etoposide—brain cancer	0.00025	0.00162	CcSEcCtD
Bosentan—Cardiac disorder—Etoposide—brain cancer	0.00025	0.00162	CcSEcCtD
Bosentan—Arthralgia—Temozolomide—brain cancer	0.00025	0.00162	CcSEcCtD
Bosentan—Rash—Procarbazine—brain cancer	0.000249	0.00162	CcSEcCtD
Bosentan—Dermatitis—Procarbazine—brain cancer	0.000249	0.00162	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000249	0.00511	CbGpPWpGaD
Bosentan—Anxiety—Temozolomide—brain cancer	0.000249	0.00161	CcSEcCtD
Bosentan—Headache—Procarbazine—brain cancer	0.000248	0.00161	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000248	0.00161	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—ABR—brain cancer	0.000248	0.00509	CbGpPWpGaD
Bosentan—Oedema—Carmustine—brain cancer	0.000248	0.00161	CcSEcCtD
Bosentan—Discomfort—Temozolomide—brain cancer	0.000247	0.0016	CcSEcCtD
Bosentan—Infection—Carmustine—brain cancer	0.000246	0.0016	CcSEcCtD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000246	0.00504	CbGpPWpGaD
Bosentan—Angiopathy—Etoposide—brain cancer	0.000244	0.00159	CcSEcCtD
Bosentan—Dry mouth—Temozolomide—brain cancer	0.000244	0.00158	CcSEcCtD
Bosentan—Immune system disorder—Etoposide—brain cancer	0.000243	0.00158	CcSEcCtD
Bosentan—Mediastinal disorder—Etoposide—brain cancer	0.000243	0.00158	CcSEcCtD
Bosentan—Thrombocytopenia—Carmustine—brain cancer	0.000242	0.00157	CcSEcCtD
Bosentan—Body temperature increased—Hydroxyurea—brain cancer	0.000242	0.00157	CcSEcCtD
Bosentan—Chills—Etoposide—brain cancer	0.000242	0.00157	CcSEcCtD
Bosentan—Tachycardia—Carmustine—brain cancer	0.000242	0.00157	CcSEcCtD
Bosentan—Anaphylactic shock—Temozolomide—brain cancer	0.000239	0.00155	CcSEcCtD
Bosentan—Oedema—Temozolomide—brain cancer	0.000239	0.00155	CcSEcCtD
Bosentan—Infection—Temozolomide—brain cancer	0.000238	0.00154	CcSEcCtD
Bosentan—Anorexia—Carmustine—brain cancer	0.000236	0.00153	CcSEcCtD
Bosentan—Nausea—Procarbazine—brain cancer	0.000235	0.00152	CcSEcCtD
Bosentan—Nervous system disorder—Temozolomide—brain cancer	0.000235	0.00152	CcSEcCtD
Bosentan—Thrombocytopenia—Temozolomide—brain cancer	0.000234	0.00152	CcSEcCtD
Bosentan—Skin disorder—Temozolomide—brain cancer	0.000232	0.00151	CcSEcCtD
Bosentan—Hypotension—Carmustine—brain cancer	0.000231	0.0015	CcSEcCtD
Bosentan—Hyperhidrosis—Temozolomide—brain cancer	0.000231	0.0015	CcSEcCtD
Bosentan—Anorexia—Temozolomide—brain cancer	0.000228	0.00148	CcSEcCtD
Bosentan—Back pain—Etoposide—brain cancer	0.000227	0.00147	CcSEcCtD
Bosentan—Hypersensitivity—Hydroxyurea—brain cancer	0.000226	0.00146	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Carmustine—brain cancer	0.000225	0.00146	CcSEcCtD
Bosentan—Muscle spasms—Etoposide—brain cancer	0.000225	0.00146	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—ABR—brain cancer	0.000225	0.00462	CbGpPWpGaD
Bosentan—Insomnia—Carmustine—brain cancer	0.000224	0.00145	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—DTX2—brain cancer	0.000223	0.00459	CbGpPWpGaD
Bosentan—Paraesthesia—Carmustine—brain cancer	0.000222	0.00144	CcSEcCtD
Bosentan—Dyspnoea—Carmustine—brain cancer	0.000221	0.00143	CcSEcCtD
Bosentan—Somnolence—Carmustine—brain cancer	0.00022	0.00143	CcSEcCtD
Bosentan—Asthenia—Hydroxyurea—brain cancer	0.00022	0.00143	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000218	0.00141	CcSEcCtD
Bosentan—Anaemia—Etoposide—brain cancer	0.000217	0.00141	CcSEcCtD
Bosentan—Insomnia—Temozolomide—brain cancer	0.000216	0.0014	CcSEcCtD
Bosentan—Decreased appetite—Carmustine—brain cancer	0.000215	0.0014	CcSEcCtD
Bosentan—Paraesthesia—Temozolomide—brain cancer	0.000215	0.00139	CcSEcCtD
Bosentan—Gastrointestinal disorder—Carmustine—brain cancer	0.000214	0.00139	CcSEcCtD
Bosentan—Dyspnoea—Temozolomide—brain cancer	0.000213	0.00138	CcSEcCtD
Bosentan—Somnolence—Temozolomide—brain cancer	0.000213	0.00138	CcSEcCtD
Bosentan—Pain—Carmustine—brain cancer	0.000212	0.00137	CcSEcCtD
Bosentan—Constipation—Carmustine—brain cancer	0.000212	0.00137	CcSEcCtD
Bosentan—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000211	0.00434	CbGpPWpGaD
Bosentan—Vertigo—Etoposide—brain cancer	0.000211	0.00137	CcSEcCtD
Bosentan—Dyspepsia—Temozolomide—brain cancer	0.000211	0.00137	CcSEcCtD
Bosentan—Leukopenia—Etoposide—brain cancer	0.00021	0.00136	CcSEcCtD
Bosentan—Diarrhoea—Hydroxyurea—brain cancer	0.000209	0.00136	CcSEcCtD
Bosentan—Decreased appetite—Temozolomide—brain cancer	0.000208	0.00135	CcSEcCtD
Bosentan—Gastrointestinal disorder—Temozolomide—brain cancer	0.000206	0.00134	CcSEcCtD
Bosentan—Fatigue—Temozolomide—brain cancer	0.000206	0.00134	CcSEcCtD
Bosentan—Loss of consciousness—Etoposide—brain cancer	0.000206	0.00134	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—SHH—brain cancer	0.000206	0.00423	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PTCH2—brain cancer	0.000205	0.00421	CbGpPWpGaD
Bosentan—Cough—Etoposide—brain cancer	0.000205	0.00133	CcSEcCtD
Bosentan—Constipation—Temozolomide—brain cancer	0.000205	0.00133	CcSEcCtD
Bosentan—Pain—Temozolomide—brain cancer	0.000205	0.00133	CcSEcCtD
Bosentan—Dizziness—Hydroxyurea—brain cancer	0.000202	0.00131	CcSEcCtD
Bosentan—Gastrointestinal pain—Carmustine—brain cancer	0.000202	0.00131	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000202	0.00414	CbGpPWpGaD
Bosentan—Chest pain—Etoposide—brain cancer	0.0002	0.0013	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000198	0.00129	CcSEcCtD
Bosentan—Discomfort—Etoposide—brain cancer	0.000197	0.00128	CcSEcCtD
Bosentan—Abdominal pain—Carmustine—brain cancer	0.000196	0.00127	CcSEcCtD
Bosentan—Body temperature increased—Carmustine—brain cancer	0.000196	0.00127	CcSEcCtD
Bosentan—Gastrointestinal pain—Temozolomide—brain cancer	0.000196	0.00127	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—SMO—brain cancer	0.000195	0.00401	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—PTCH1—brain cancer	0.000195	0.00401	CbGpPWpGaD
Bosentan—Vomiting—Hydroxyurea—brain cancer	0.000195	0.00126	CcSEcCtD
Bosentan—Rash—Hydroxyurea—brain cancer	0.000193	0.00125	CcSEcCtD
Bosentan—Dermatitis—Hydroxyurea—brain cancer	0.000193	0.00125	CcSEcCtD
Bosentan—Headache—Hydroxyurea—brain cancer	0.000192	0.00124	CcSEcCtD
Bosentan—Anaphylactic shock—Etoposide—brain cancer	0.000191	0.00124	CcSEcCtD
Bosentan—Infection—Etoposide—brain cancer	0.00019	0.00123	CcSEcCtD
Bosentan—Urticaria—Temozolomide—brain cancer	0.00019	0.00123	CcSEcCtD
Bosentan—Abdominal pain—Temozolomide—brain cancer	0.000189	0.00123	CcSEcCtD
Bosentan—Body temperature increased—Temozolomide—brain cancer	0.000189	0.00123	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—OR4C12—brain cancer	0.000188	0.00386	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—OR14C36—brain cancer	0.000188	0.00386	CbGpPWpGaD
Bosentan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000188	0.00385	CbGpPWpGaD
Bosentan—Thrombocytopenia—Etoposide—brain cancer	0.000187	0.00122	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000187	0.00384	CbGpPWpGaD
Bosentan—Tachycardia—Etoposide—brain cancer	0.000187	0.00121	CcSEcCtD
Bosentan—Skin disorder—Etoposide—brain cancer	0.000186	0.00121	CcSEcCtD
Bosentan—Hyperhidrosis—Etoposide—brain cancer	0.000185	0.0012	CcSEcCtD
Bosentan—Anorexia—Etoposide—brain cancer	0.000182	0.00118	CcSEcCtD
Bosentan—Hypersensitivity—Carmustine—brain cancer	0.000182	0.00118	CcSEcCtD
Bosentan—Nausea—Hydroxyurea—brain cancer	0.000182	0.00118	CcSEcCtD
Bosentan—Hypotension—Etoposide—brain cancer	0.000179	0.00116	CcSEcCtD
Bosentan—Asthenia—Carmustine—brain cancer	0.000178	0.00115	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—ABR—brain cancer	0.000177	0.00364	CbGpPWpGaD
Bosentan—Hypersensitivity—Temozolomide—brain cancer	0.000176	0.00114	CcSEcCtD
Bosentan—Paraesthesia—Etoposide—brain cancer	0.000172	0.00112	CcSEcCtD
Bosentan—Asthenia—Temozolomide—brain cancer	0.000172	0.00111	CcSEcCtD
Bosentan—Dyspnoea—Etoposide—brain cancer	0.000171	0.00111	CcSEcCtD
Bosentan—Somnolence—Etoposide—brain cancer	0.00017	0.0011	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—PTCH2—brain cancer	0.000169	0.00348	CbGpPWpGaD
Bosentan—Diarrhoea—Carmustine—brain cancer	0.000169	0.0011	CcSEcCtD
Bosentan—Pruritus—Temozolomide—brain cancer	0.000169	0.0011	CcSEcCtD
Bosentan—Decreased appetite—Etoposide—brain cancer	0.000166	0.00108	CcSEcCtD
Bosentan—Gastrointestinal disorder—Etoposide—brain cancer	0.000165	0.00107	CcSEcCtD
Bosentan—Fatigue—Etoposide—brain cancer	0.000165	0.00107	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—HES5—brain cancer	0.000164	0.00337	CbGpPWpGaD
Bosentan—Dizziness—Carmustine—brain cancer	0.000164	0.00106	CcSEcCtD
Bosentan—Constipation—Etoposide—brain cancer	0.000164	0.00106	CcSEcCtD
Bosentan—Pain—Etoposide—brain cancer	0.000164	0.00106	CcSEcCtD
Bosentan—Diarrhoea—Temozolomide—brain cancer	0.000164	0.00106	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ABR—brain cancer	0.000161	0.00331	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DTX2—brain cancer	0.00016	0.00328	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STRADA—brain cancer	0.000159	0.00327	CbGpPWpGaD
Bosentan—Dizziness—Temozolomide—brain cancer	0.000158	0.00103	CcSEcCtD
Bosentan—Vomiting—Carmustine—brain cancer	0.000157	0.00102	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—TRPC6—brain cancer	0.000157	0.00322	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Etoposide—brain cancer	0.000157	0.00102	CcSEcCtD
Bosentan—Rash—Carmustine—brain cancer	0.000156	0.00101	CcSEcCtD
Bosentan—Dermatitis—Carmustine—brain cancer	0.000156	0.00101	CcSEcCtD
Bosentan—Headache—Carmustine—brain cancer	0.000155	0.00101	CcSEcCtD
Bosentan—Vomiting—Temozolomide—brain cancer	0.000152	0.000987	CcSEcCtD
Bosentan—Urticaria—Etoposide—brain cancer	0.000152	0.000987	CcSEcCtD
Bosentan—Body temperature increased—Etoposide—brain cancer	0.000151	0.000982	CcSEcCtD
Bosentan—Abdominal pain—Etoposide—brain cancer	0.000151	0.000982	CcSEcCtD
Bosentan—Rash—Temozolomide—brain cancer	0.000151	0.000979	CcSEcCtD
Bosentan—Dermatitis—Temozolomide—brain cancer	0.000151	0.000978	CcSEcCtD
Bosentan—Headache—Temozolomide—brain cancer	0.00015	0.000972	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—SHH—brain cancer	0.000148	0.00303	CbGpPWpGaD
Bosentan—Nausea—Carmustine—brain cancer	0.000147	0.000954	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—TRPC6—brain cancer	0.000142	0.00292	CbGpPWpGaD
Bosentan—Nausea—Temozolomide—brain cancer	0.000142	0.000922	CcSEcCtD
Bosentan—Hypersensitivity—Etoposide—brain cancer	0.000141	0.000915	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—SMO—brain cancer	0.00014	0.00287	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PTCH1—brain cancer	0.00014	0.00287	CbGpPWpGaD
Bosentan—Asthenia—Etoposide—brain cancer	0.000137	0.000891	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000137	0.00281	CbGpPWpGaD
Bosentan—Pruritus—Etoposide—brain cancer	0.000135	0.000879	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ABR—brain cancer	0.000133	0.00273	CbGpPWpGaD
Bosentan—Diarrhoea—Etoposide—brain cancer	0.000131	0.00085	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—GLI2—brain cancer	0.000128	0.00264	CbGpPWpGaD
Bosentan—Dizziness—Etoposide—brain cancer	0.000127	0.000821	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000126	0.00259	CbGpPWpGaD
Bosentan—Vomiting—Etoposide—brain cancer	0.000122	0.00079	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PTCH2—brain cancer	0.000121	0.00249	CbGpPWpGaD
Bosentan—Rash—Etoposide—brain cancer	0.000121	0.000783	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—GLI1—brain cancer	0.000121	0.00248	CbGpPWpGaD
Bosentan—Dermatitis—Etoposide—brain cancer	0.000121	0.000782	CcSEcCtD
Bosentan—Headache—Etoposide—brain cancer	0.00012	0.000778	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—VAV1—brain cancer	0.000117	0.00241	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HES5—brain cancer	0.000117	0.00241	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SUFU—brain cancer	0.000114	0.00235	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STRADA—brain cancer	0.000114	0.00234	CbGpPWpGaD
Bosentan—Nausea—Etoposide—brain cancer	0.000114	0.000738	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—TRPC6—brain cancer	0.000112	0.0023	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GFAP—brain cancer	0.00011	0.00227	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000107	0.0022	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—VAV1—brain cancer	0.000107	0.00219	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00217	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—SHH—brain cancer	0.000106	0.00217	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HEY1—brain cancer	0.000105	0.00215	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DLL1—brain cancer	0.000103	0.00211	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TRPC6—brain cancer	0.000102	0.00209	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—SMO—brain cancer	0.0001	0.00206	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PTCH1—brain cancer	0.0001	0.00206	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ABR—brain cancer	9.51e-05	0.00195	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GLI2—brain cancer	9.19e-05	0.00189	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	9.02e-05	0.00185	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SHH—brain cancer	8.72e-05	0.00179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GLI1—brain cancer	8.64e-05	0.00177	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TRPC6—brain cancer	8.41e-05	0.00173	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—VAV1—brain cancer	8.41e-05	0.00173	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2C9—brain cancer	8.33e-05	0.00171	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SMO—brain cancer	8.27e-05	0.0017	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTCH1—brain cancer	8.27e-05	0.0017	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SUFU—brain cancer	8.19e-05	0.00168	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GFAP—brain cancer	7.9e-05	0.00162	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—VAV1—brain cancer	7.64e-05	0.00157	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HEY1—brain cancer	7.49e-05	0.00154	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CG—brain cancer	7.46e-05	0.00153	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DLL1—brain cancer	7.34e-05	0.00151	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—BSG—brain cancer	7.08e-05	0.00145	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CG—brain cancer	6.78e-05	0.00139	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOTCH2—brain cancer	6.61e-05	0.00136	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VAV1—brain cancer	6.3e-05	0.00129	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SHH—brain cancer	6.24e-05	0.00128	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—IDH1—brain cancer	6.09e-05	0.00125	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TRPC6—brain cancer	6.02e-05	0.00124	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SMO—brain cancer	5.92e-05	0.00122	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTCH1—brain cancer	5.92e-05	0.00122	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HES1—brain cancer	5.42e-05	0.00111	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CG—brain cancer	5.34e-05	0.0011	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—brain cancer	5.25e-05	0.00108	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDGFRA—brain cancer	5.16e-05	0.00106	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SPP1—brain cancer	5.01e-05	0.00103	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.96e-05	0.00102	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CG—brain cancer	4.85e-05	0.000996	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ENO2—brain cancer	4.81e-05	0.000988	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—brain cancer	4.77e-05	0.000979	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOTCH2—brain cancer	4.73e-05	0.000972	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.56e-05	0.000937	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IRS2—brain cancer	4.53e-05	0.000931	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VAV1—brain cancer	4.51e-05	0.000926	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CG—brain cancer	4e-05	0.000822	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—brain cancer	4e-05	0.000822	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HES1—brain cancer	3.88e-05	0.000797	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—brain cancer	3.76e-05	0.000772	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFRA—brain cancer	3.69e-05	0.000759	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—brain cancer	3.65e-05	0.000749	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SPP1—brain cancer	3.59e-05	0.000736	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—brain cancer	3.41e-05	0.000701	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS2—brain cancer	3.24e-05	0.000666	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RELA—brain cancer	3.13e-05	0.000642	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB2—brain cancer	3.11e-05	0.000638	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—brain cancer	2.86e-05	0.000588	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—brain cancer	2.86e-05	0.000588	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—brain cancer	2.82e-05	0.000578	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—brain cancer	2.75e-05	0.000564	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CTNNB1—brain cancer	2.72e-05	0.000558	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—brain cancer	2.61e-05	0.000536	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—brain cancer	2.39e-05	0.000491	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—brain cancer	2.37e-05	0.000487	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BSG—brain cancer	2.36e-05	0.000485	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RELA—brain cancer	2.24e-05	0.00046	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB2—brain cancer	2.22e-05	0.000457	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—brain cancer	2.21e-05	0.000453	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—brain cancer	2.2e-05	0.000452	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—brain cancer	2.15e-05	0.000442	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—IDH1—brain cancer	2.03e-05	0.000417	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—brain cancer	2.02e-05	0.000414	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—brain cancer	1.96e-05	0.000403	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CTNNB1—brain cancer	1.95e-05	0.0004	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2C9—brain cancer	1.83e-05	0.000376	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—brain cancer	1.81e-05	0.000371	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—brain cancer	1.71e-05	0.000352	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—brain cancer	1.7e-05	0.000348	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.65e-05	0.00034	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ENO2—brain cancer	1.61e-05	0.00033	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—brain cancer	1.58e-05	0.000324	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BSG—brain cancer	1.56e-05	0.00032	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—brain cancer	1.54e-05	0.000317	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—IDH1—brain cancer	1.34e-05	0.000275	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—brain cancer	1.29e-05	0.000266	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ENO2—brain cancer	1.06e-05	0.000218	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—brain cancer	7.37e-06	0.000151	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—brain cancer	4.86e-06	9.98e-05	CbGpPWpGaD
